413 related articles for article (PubMed ID: 32416701)
1. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Rahim H; Rashid U; Ahmad S; Jan MS; Ullah R; Shahat AA; Mahmood HM
Drug Des Devel Ther; 2019; 13():4185-4194. PubMed ID: 31849450
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
[TBL] [Abstract][Full Text] [Related]
5. Amino Acid Conjugates of Aminothiazole and Aminopyridine as Potential Anticancer Agents: Synthesis, Molecular Docking and in vitro Evaluation.
Naz S; Shah FA; Nadeem H; Sarwar S; Tan Z; Imran M; Ali T; Li JB; Li S
Drug Des Devel Ther; 2021; 15():1459-1476. PubMed ID: 33833504
[TBL] [Abstract][Full Text] [Related]
6. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
[TBL] [Abstract][Full Text] [Related]
7. Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent.
Mittal RK; Purohit P
Anticancer Agents Med Chem; 2020; 20(16):1981-1991. PubMed ID: 32560612
[TBL] [Abstract][Full Text] [Related]
8. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
Toan DN; Thanh ND; Truong MX; Van DT
Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of N-(4-(substituted)-3-(trifluoromethyl) phenyl) isobutyramides and their N-ethyl analogous as anticancer, anti-angiogenic & antioxidant agents: In vitro and in silico analysis.
Sawant AS; Kamble SS; Pisal PM; Sawant SS; Hese SV; Bagul KT; Pinjari RV; Kamble VT; Meshram RJ; Gacche RN
Comput Biol Chem; 2021 Jun; 92():107484. PubMed ID: 33865034
[TBL] [Abstract][Full Text] [Related]
14. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
16. 8-Alkylmercaptocaffeine derivatives: antioxidant, molecular docking, and in-vitro cytotoxicity studies.
Sargazi S; Shahraki S; Shahraki O; Zargari F; Sheervalilou R; Maghsoudi S; Soltani Rad MN; Saravani R
Bioorg Chem; 2021 Jun; 111():104900. PubMed ID: 33894429
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
18. Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation.
Ashraf Z; Mahmood T; Hassan M; Afzal S; Rafique H; Afzal K; Latip J
Drug Des Devel Ther; 2019; 13():1643-1657. PubMed ID: 31190743
[TBL] [Abstract][Full Text] [Related]
19. Isothymusin, a Potential Inhibitor of Cancer Cell Proliferation: An In Silico and In Vitro Investigation.
Singh S; Kumari P; Hussain Y; Luqman S; Meena A; Kanaojia D
Curr Top Med Chem; 2020; 20(21):1898-1909. PubMed ID: 32648844
[TBL] [Abstract][Full Text] [Related]
20. In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5
Hussain S; Ullah F; Ayaz M; Ali Shah SA; Ali Shah AU; Shah SM; Wadood A; Aman W; Ullah R; Shahat AA; Nasr FA
Drug Des Devel Ther; 2019; 13():4195-4205. PubMed ID: 31849451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
